Home | My Account | Online Store | Contact & Demand | Press Room | About Us | FAQs
Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

  

Search in our Online Store
Medical Devices & Biomaterials
Filter     Order     Display # 
Date Item Title
02 Jun 2007 Abbott Submits XIENCE(TM) V Everolimus Eluting Coronary Stent System Application for U.S. FDA Approval
01 Jun 2007 MIV Therapeutics Announces Start of Clinical Trial Marking First Ever Human Implantation of A Hydroxyapatite Coated Stent
01 Jun 2007 Northstar Neuroscience Announces the Completion of Subject Enrollment and Randomization in the EVEREST Pivotal Trial for Upper Extremity Motor Recovery in Stroke Survivors
30 May 2007 Angiotech initiates european trial examining the Vascular Wrap™ paclitaxel-eluting mesh for dialysis patients with end-stage renal disease
24 May 2007 Abbott Initiates First Clinical Study of Everolimus Eluting Stent System for Patients with Peripheral Arterial Disease
23 May 2007 Abbott Announces Positive Nine-Month Results from the World's First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
22 May 2007 Medtronic Announces Start of 8,800-Patient Clinical Trial Evaluating Drug-Eluting Stent Safety
22 May 2007 Oculus Initiates Patient Enrollment in Phase II Study of Microcyn(R) Technology for Treatment of Mild Diabetic Foot Infections
08 May 2007 Conor Medsystems, LLC Reports COSTAR II Pivotal Drug-Eluting Stent Trial Conclusions
03 May 2007 Quest PharmaTech's Prostate Cancer Program Update
02 May 2007 KCI Announces Positive Results From Clinical Study Utilizing V.A.C.(R) Therapy in the Treatment of Diabetic Foot Ulcers
01 May 2007 Northstar Neuroscience Announces Initial Feasibility Data on the Use of its Renova(TM) Cortical Stimulation System to Treat Tinnitus
27 Apr 2007 Boston Scientific Announces Completion of Enrollment in Landmark Clinical Trial Comparing Drug-Eluting Stents To Cardiac Surgery
19 Apr 2007 Vasogen and Grupo Ferrer Form Collaboration to Commercialize Celacade(TM) in the European Union
18 Apr 2007 Wockhardt to soon introduce Kelocote to treat scars
22 Mar 2007 Fralex Therapeutics Inc. initiates pivotal trial for chronic pain associated with fibromyalgia
20 Mar 2007 Angiotech Initiates U.S. Pivotal Trial for the Vascular Wrap Paclitaxel-Eluting Mesh
01 Mar 2007 St. Jude Medical Announces Spinal Cord Stimulation Pilot Study for Chronic Angina
22 Feb 2007 Orthovita Announces Completion of Patient Enrollment in Its U.S. Pivotal Clinical Study for the Use of CORTOSS(R) in the Treatment of Vertebral Compression Fractures
21 Feb 2007 Cyberkinetics Files to Market Andara(TM) OFS(TM) Therapy for Acute Spinal Cord Injury under Humanitarian Device Exemption
10 Feb 2007 Q-Med has entered into a development and commercialisation agreement regarding botulinum toxin products
09 Feb 2007 BioSyntech announces start of patient recruitment into BST-DermOn(TM) pivotal clinical trial
09 Feb 2007 Advanced BioHealing Enrolls First Patient in Celaderm Pilot Venous Leg Ulcer Clinical Trial
09 Feb 2007 In-licensing of MuGard(TM) from Access Pharmaceuticals
31 Jan 2007 First International Trial of Drug-Eluting Peripheral Artery Stent Results Encouraging
30 Jan 2007 OccuLogix's RHEO-AMD Trial Protocol Cleared by the FDA
26 Jan 2007 BioMimetic Therapeutics Reports Positive Clinical Results Using GEM OS®1 to Treat Distal Radius Fractures
25 Jan 2007 Scil Technology Completes Patient Enrollment in European Phase II Sinus Lift Study
23 Jan 2007 Innocoll Receives FDA Approval to Commence a Phase 2 Clinical Trial for the Topical Treatment of Infected Diabetic Foot Ulcers With its CollaRx(R) GENTAMICIN
13 Jan 2007 Biocoral, Inc. Announces the Results of the Final Report of its Prospective Randomised Clinical Multi-Centre Trial for Treatment of Hip Fractures Associated With Natural Bone Demineralization/or Low Bone Mass
29 Dec 2006 SciClone Submits Regulatory Application for DC Bead in China
08 Dec 2006 OMRIX Biopharmaceuticals Commences Phase 1 Clinical Trial for Fibrin Patch
07 Dec 2006 BSD Medical Announces Completion of 340 Patient Cancer Study
01 Dec 2006 SOLESTA receives approval in Europe for treatment of fecal incontinence
30 Nov 2006 Micrus Endovascular Announces Positive Results from Prospective Cerecyte Study
29 Nov 2006 Anika Therapeutics Receives FDA Approvable Letter for its Cosmetic Tissue Augmentation Product
17 Nov 2006 Angiotech Submits Application for European Regulatory Approval for its Vascular Wrap(TM) Product
11 Nov 2006 Advanced BioHealing Initiates CeladermTM Clinical Trial
10 Nov 2006 Innocoll Announces Investigational New Drug Application Filing for its CollaRx GENTAMICIN as a Topical Treatment for Infected Diabetic Foot Ulcers
10 Nov 2006 Angiotech's Vascular Wrap™ trial results demonstrate reduced incidence of amputation
04 Nov 2006 Approval of NexStent(R) Carotid Artery Stenting System
31 Oct 2006 Mentor Executes Agreement with Genzyme to Partner on Future Development and Commercialization of Hyaluronic Acid Dermal Fillers
26 Oct 2006 The Optobionics Pilot Clinical Study Shows Promising Vision Improvement for Retinitis Pigmentosa Patients
25 Oct 2006 Abbott Reports Initial Results from World's First Clinical Trial Featuring a Fully Bioabsorbable Drug-eluting Coronary Stent
20 Oct 2006 Medtronic Announces Largest Clinical Study Evaluating Drug-Eluting Stent Safety
17 Oct 2006 Boston Scientific Becomes only Company with Two Drug-Eluting Stent Platforms With European Approval of Everolimus-Eluting PROMUS(TM) Stent System
17 Oct 2006 Pegasus Biologics Enters Wound Care Market With FDA Clearance for DermADAPT™ Biomatrix
13 Oct 2006 EKR Therapeutics Acquires Exclusive License for Gelclair® from Helsinn Healthcare SA
13 Oct 2006 Innocoll, Inc. Receives FDA Approval for CollaGUARD™, A Collagen-Based
10 Oct 2006 Medtronic Receives FDA Approval To Study Infuse Bone Graft In The Cervical Spine
 
<< Start < Prev 1 2 3 4 5 6 Next > End >>
Results 51 - 100 of 271

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Thrombopoiesis-Stimulating Agents (TPO)

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonists & Antagonists

Order Now

Subscribe La Merie Biologics